Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

ampicillin sodium 500mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

ampicillin sodium 500mg

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - epicillin - capsule - 250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bridge pharmaceuticals (ire) ltd - epicillin - capsule - 500 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - epicillin - withdrawn form - 1 g/100ml

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - epicillin - withdrawn form - 500 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - epicillin - withdrawn form - 250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - epicillin - 125 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - epicillin - 250 milligram

United States - English - NLM (National Library of Medicine)

par pharmaceutical - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.  when culture and susceptibility information are available, they should be considered in selecting of modifying antimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea - e. coli, p. mirabilis , enterococci, shigella, s. typhosa and other salmonella and nonpenicillinase-producing n. gonorrhoeae . infections of the respiratory tract - nonpenicillinase-producing